Erasca’s $345 Million Initial Public Offering

Latham & Watkins LLP and Wilson Sonsini Goodrich & Rosati represented Erasca in the transaction.

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, announced the closing of its initial public offering of 21,562,500 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase 2,812,500 additional shares, at an initial public offering price of $16.00 per share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Erasca, were $345.0 million. Erasca’s common stock is listed on the Nasdaq Global Select Market under the ticker symbol “ERAS.”

J.P. Morgan, Morgan Stanley, BofA Securities, Evercore ISI, and Guggenheim Securities acted as joint book-running managers for the offering.

Latham & Watkins LLP represented Erasca, Inc. in the offering with a corporate deal team led by San Diego partners Cheston Larson (Picture) and Matt Bush, with associates Alaina Ellis, Claire Hutar, Ty Balzer and Shelby Harrison. Advice was also provided on benefits and compensation matters by San Diego partner Holly Bauer, with Chicago associate Victoria Wolfe; on FDA regulatory matters by Washington, D.C. partner Elizabeth Richards and Bay Area counsel Betty Pang, with Washington, D.C. associates Chad Jennings and Margaret Rote; on intellectual property matters by Bay Area/San Diego partner Chris Hazuka, with San Diego associate Robert Yeh; on data privacy matters by Bay Area counsel Heather Deixler; and on tax matters by Century City partner Sam Weiner, with associate Brian Rogers.

A Wilson Sonsini Goodrich & Rosati team including Deborah Smith, Céline Bonnefous, Chen Zhao, Matt Wheeler, and Mike Hostetler? advised Erasca on intellectual property matters related to the transaction.

Involved fees earner: Ty Balzer – Latham & Watkins; Holly Bauer – Latham & Watkins; Matthew Bush – Latham & Watkins; Heather Deixler – Latham & Watkins; Alaina Ellis – Latham & Watkins; Shelby Harrison – Latham & Watkins; Christopher Hazuka – Latham & Watkins; Claire Hutar – Latham & Watkins; Chad Jennings – Latham & Watkins; Cheston Larson – Latham & Watkins; Betty Pang – Latham & Watkins; Elizabeth Richards – Latham & Watkins; Brian Rogers – Latham & Watkins; Margaret Rote – Latham & Watkins; Samuel Weiner – Latham & Watkins; Victoria Wolfe – Latham & Watkins; Robert Yeh – Latham & Watkins; Celine Bonnefous – Wilson Sonsini Goodrich & Rosati; Michael Hostetler – Wilson Sonsini Goodrich & Rosati; Deborah Smith – Wilson Sonsini Goodrich & Rosati; Matt Wheeler – Wilson Sonsini Goodrich & Rosati; Chen Zhao – Wilson Sonsini Goodrich & Rosati;

Law Firms: Latham & Watkins; Wilson Sonsini Goodrich & Rosati;

Clients: Erasca Inc.;

Author: Martina Bellini